HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.

Abstract
A novel group of hybrid calcium channel (CC) modulators was prepared where the isopropyl ester moiety of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate (PN 202-791) was replaced by a variety of nitric oxide (*NO) donor nitrooxyalkyl ester substituents. Enantiomers, or diastereomers, having the (R)-configuration at the C-4 position of the 1,4-dihydropyridine ring (1,4-DHP) exhibited more potent in vitro CC antagonist activity on guinea pig ileum longitudinal smooth muscle (GPILSM) than compounds having the (4S)-configuration. None of the nitrooxyalkyl compounds exhibited a contraindicated CC agonist effect on GPILSM that would cause smooth muscle contraction. Structure-activity studies showed the enantiomers having the (S)-configuration at the C-4 position of the 1,4-DHP ring or diastereomers having the a (4S)-configuration at the C-4 position of the 1,4-DHP ring in conjunction with a (1R-)-1-methyl-2-nitrooxyethyl ester substituent exhibited the most potent cardiac CC agonist (positive inotropic) activity on guinea pig left atrium (GPLA). This class of compounds releases *NO in vitro that is enhanced by the presence of a thiol such as N-acetylcysteamine. The novel *NO donor (-)-(S,R)-1-methyl-2-nitrooxyethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate [(-)-(S,R)-38], which acts as a dual cardioselective calcium channel agonist (GPLA)/smooth muscle selective calciumchannel antagonist (GPILSM), is a useful lead compound for drug discovery targeted to the treatment of congestive heart failure, and it provides a useful research probe to study the structure-function relationship of calcium channels.
AuthorsRudong Shan, Carlos Velazquez, Edward E Knaus
JournalJournal of medicinal chemistry (J Med Chem) Vol. 47 Issue 1 Pg. 254-61 (Jan 01 2004) ISSN: 0022-2623 [Print] United States
PMID14695839 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 1-methyl-2-nitrooxyethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate
  • Calcium Channel Blockers
  • Calcium Channels
  • Nitrates
  • Nitric Oxide Donors
  • Oxadiazoles
  • Nitric Oxide
Topics
  • Animals
  • Calcium Channel Blockers (chemical synthesis, chemistry, pharmacology)
  • Calcium Channels (drug effects)
  • Guinea Pigs
  • Heart (drug effects, physiology)
  • Ileum (drug effects, physiology)
  • In Vitro Techniques
  • Muscle Contraction (drug effects)
  • Muscle, Smooth (drug effects, metabolism, physiology)
  • Myocardium (metabolism)
  • Nitrates (chemical synthesis, chemistry, pharmacology)
  • Nitric Oxide (chemistry)
  • Nitric Oxide Donors (chemical synthesis, chemistry, pharmacology)
  • Oxadiazoles (chemical synthesis, chemistry, pharmacology)
  • Stereoisomerism
  • Stimulation, Chemical
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: